Anhui Huaheng Biotechnology Stock Current Asset

688639 Stock   29.49  1.44  4.66%   
Anhui Huaheng Biotechnology fundamentals help investors to digest information that contributes to Anhui Huaheng's financial success or failures. It also enables traders to predict the movement of Anhui Stock. The fundamental analysis module provides a way to measure Anhui Huaheng's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anhui Huaheng stock.
At present, Anhui Huaheng's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 135.8 M, whereas Total Current Assets are forecasted to decline to about 707 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Anhui Huaheng Biotechnology Company Current Asset Analysis

Anhui Huaheng's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

Anhui Total Assets

Total Assets

4.79 Billion

At present, Anhui Huaheng's Total Assets are projected to increase significantly based on the last few years of reporting.
In accordance with the recently published financial statements, Anhui Huaheng Biotechnology has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all China stocks is 100.0% higher than that of the company.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Anhui Fundamentals

About Anhui Huaheng Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Anhui Huaheng Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anhui Huaheng using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anhui Huaheng Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Anhui Stock

Anhui Huaheng financial ratios help investors to determine whether Anhui Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anhui with respect to the benefits of owning Anhui Huaheng security.